Robledo NR, Ruiz SJC, Méndez EF, Trujillo CR, Blanco CM

Idioma: Español
Referencias bibliográficas: 30
Paginas: 89-95
Archivo PDF: 90.86 Kb.

RESUMEN

La insuficiencia cardíaca avanzada es un problema de salud mundial a pesar de la terapéutica actual. Los pacientes con miocardiopatía dilatada (MCD) presentan muerte súbita por arritmias ventriculares en el 30% al 60%. Tanto el desfibrilador cardioverter automático implantable (DCAI) como la resincronización biventricular (RBV) en forma independiente han demostrado ser efectivos y seguros para lo que fueron destinados. Actualmente están en proceso varios estudios asociando estos dispositivos y los resultados son alentadores. El propósito del presente trabajo es reportar los primeros tres casos en México con ambos dispositivos, en uno se asoció un marcapaso con un DCAI y los otros dos con dispositivos que tienen ambas funciones. Se incluyeron tres hombres con edades de 63, 65 y 54 años, dos de ellos con historia de infarto, en clase funcional de la NYHA de II a IV, fracción de expulsión del ventrículo izquierdo (FEVI) de 25, 35 y 25%. Los tres mejoraron su clase funcional y la FEVI y dos han presentado descargas del DCAI.

REFERENCIAS (EN ESTE ARTÍCULO)

1. MERIT-HF study group: Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2001-07.

2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.

3. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al: Canadian Implantable Defibrillator Study (CIDS): a randomized study of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-1302.

4. AVID Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.

5. Kuck K, Cappato R, Siebels J, Ruppel R: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-754.

6. Josephson ME, Callans DJ, Buxton AE: The Role of the Implantable Cardioverter Defibrillator for Prevention of Sudden Cardiac Death. Ann Intern Med 2002; 133: 901-910.

7. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al: Improved survival with an implantable defibrillator in patients with coronary artery disease at high risk of ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-1940.

8. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of prevention of Sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882-1890.

9. Cazeau S, Ritter P, Bakdach S, Lazarus A, Limousin M, Henao L, et al: Four chamber pacing in dilated cardiomyopathy. PACE 1994; 17(Pt. II): 1974-1979.

10. Gras D, Mabo P, Tang T, Luttikuis O, Chatoor R, Pedersen A, et al: Multisite pacing as a supplemental treatment of congestive heart failure. PACE 1998; 21: 2249-55.

11. Saxon L, Kerwin W, Cahalan M, Kalman J, Olguin J, Foster E: Acute effects of intraoperative multisite ventricular function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol 1998; 9: 13-21.

12. Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, et al: Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 2002; 105: 1453-1458.

13. Kuhlkamp V. The InSync 7272 ICD World Wide Investigators: Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002; 39: 790-7.

14. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al: Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart Failure: The MIRACLE ICD Trial. JAMA 2003; 289: 2685-2694.

15. Gronda E, Mangiavacchi M, Andreuzzi B, Municino A, Bologna A, Gasparini M, et al: What to spect from the new technologies in heart failure treatment. Eur Heart J 2000; 2(Suppl J): J41-J46.

16. Advisory Council to Improve Outcomes Nationwide in Heart Failure: Consensus recommendations for the management of chronic heart failure. Am J Cardiol 1999; 83(2A).

17. Wilkerson Group Survey: Congestive heart failure worldwide markets, clinical status and product development opportunities. New Medicine, Inc. 1997; Report No. 501: 1-40.

18. Sack S, Heinzel F, Dagres N, Wieneke H, Erbel R: Cardiac resynchronization therapy in terminal heart failure: current status and prospects. Herz 2001; 26: 84-88.

19. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Congestive Heart Failure/Myocardial Responses/Valvular Heart Disease: Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects. Circulation 1993; 88: 107-115.

20. Higgins SL, Yong P, Sheck D, McDaniel M, Bollinger F, Vadechaet M, for the Ventak CHF Investigators: Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000; 36: 824-827.

21. Walker S, Levy TM, Rex S, Brant S, Allen J, Ilsley CJD, et al: Usefulness of suppression of ventricular arrhythmia by biventricular pacing in severe congestive cardiac failure. Am J Cardiol 2000; 86: 231-233.

22. Zagrodzky JD, Ramaswamy K, Page RL, Joglar JA, Sheehan CJ, Smith ML, et al: Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol 2001; 87: 1208-1210.

23. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, et al: Cardiac Resynchronization and Death From Progressive Heart Failure: A Meta-analysis of Randomized Controlled Trials. JAMA 2003; 289: 730-740.

24. Saxon LA, Boehmer JP, Hummel J, Kacet S, De Marco T, Naccarelli G, et al: Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. Am J Cardiol 1999; 83: 120D-23D.

25. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al: Multisite stimulation in cardiomyopathies (MUSTIC) Study investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-880.

26. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.

27. Saxon L, De Marco T, Schafer J, Chatterjee K, Kummar UN, Foster E, et al: Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002; 105: 1304-1310.

28. Walker S, Levy T, Rex S, Brant S, Paul V: Preliminary results with the simultaneous use of implantable cardioverter defibrillators and permanent biventricular pacemaker. PACE 2000; 23: 365-372.

29. Ansalone G, Ricci R, Cacciatore G, Santini M: Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing. Ital Heart J 2001; 2(12 Suppl): 1308-1314.

30. Bocchiardo M, Padeletti L, Gasparini M, Salerno JA, Lunati M, Vivalda L, et al: Biventricular pacing in patients candidate to ICD. Eur Heart J 2000; 2(Suppl J): J36-J40.